Volume 36; Issue 3

Clinical Therapeutics

Volume 36; Issue 3
4

FDA’s Proposed Ban on Trans Fats: How Do the Costs and Benefits Stack Up?

Year:
2014
Language:
english
File:
PDF, 157 KB
english, 2014
5

No Longer “GRAS”: The Trans Fatty Acids Debate

Year:
2014
Language:
english
File:
PDF, 229 KB
english, 2014
8

From Bench to Bedside: An Overview of Rotigotine for the Treatment of Restless Legs Syndrome

Year:
2014
Language:
english
File:
PDF, 422 KB
english, 2014
11

Overview of Local, State, and National Government Legislation Restricting Trans Fats

Year:
2014
Language:
english
File:
PDF, 136 KB
english, 2014
12

Trans Fatty Acids: Are Its Cardiovascular Risks Fully Appreciated?

Year:
2014
Language:
english
File:
PDF, 171 KB
english, 2014
14

Saturated and Trans Fats

Year:
2014
Language:
english
File:
PDF, 210 KB
english, 2014
15

Erratum

Year:
2014
Language:
english
File:
PDF, 86 KB
english, 2014
16

Adverse Event Management in Mass Drug Administration for Neglected Tropical Diseases

Year:
2014
Language:
english
File:
PDF, 89 KB
english, 2014